chr17-35479459-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001363830.2(SLFN12L):c.823G>T(p.Asp275Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,614,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001363830.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLFN12L | NM_001363830.2 | c.823G>T | p.Asp275Tyr | missense_variant | 3/5 | ENST00000628453.4 | |
SLFN12L | NM_001195790.3 | c.697G>T | p.Asp233Tyr | missense_variant | 4/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLFN12L | ENST00000628453.4 | c.823G>T | p.Asp275Tyr | missense_variant | 3/5 | 5 | NM_001363830.2 | A2 | |
SLFN12L | ENST00000260908.13 | c.697G>T | p.Asp233Tyr | missense_variant | 2/4 | 5 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152238Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000479 AC: 12AN: 250384Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135716
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461802Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727190
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152356Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74506
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2023 | The c.751G>T (p.D251Y) alteration is located in exon 2 (coding exon 2) of the SLFN12L gene. This alteration results from a G to T substitution at nucleotide position 751, causing the aspartic acid (D) at amino acid position 251 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at